Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
RedHill Biopharma ( (RDHL) ) has issued an update.
At an Extraordinary General Meeting held on March 5, 2026, RedHill Biopharma shareholders approved all proposed resolutions related to equity incentives and capital structure. Investors backed grants of restricted share units tied to American Depositary Shares for non-executive directors, as well as for Chief Executive Officer and Chairman Dror Ben-Asher and Chief Commercial Officer and director Rick D. Scruggs.
Shareholders also approved an increase to RedHill Biopharma’s authorized share capital, expanding the company’s capacity to issue additional equity. The package of resolutions strengthens RedHill’s ability to align management and board incentives with shareholder interests and provides added flexibility for future financing or strategic transactions.
The most recent analyst rating on (RDHL) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on RedHill Biopharma stock, see the RDHL Stock Forecast page.
Spark’s Take on RDHL Stock
According to Spark, TipRanks’ AI Analyst, RDHL is a Neutral.
Score is held down primarily by weak financial performance (ongoing losses, negative equity, and negative operating/free cash flow). Technicals provide a partial offset with improving short-term trend and momentum, but longer-term trend and MACD remain unsupportive. Valuation impact is neutral due to missing P/E and dividend yield.
To see Spark’s full report on RDHL stock, click here.
More about RedHill Biopharma
RedHill Biopharma Ltd. is an Israel-based biopharmaceutical company listed in the United States and operating as a foreign private issuer. The company focuses on developing and commercializing therapies in the healthcare sector, using American Depositary Shares to access global capital markets and incentivize its leadership and directors through equity-based compensation.
Average Trading Volume: 502,320
Technical Sentiment Signal: Sell
Current Market Cap: $4.79M
Learn more about RDHL stock on TipRanks’ Stock Analysis page.